Accounts Payable and Accrued Liabilities (Details) $ in Thousands |
12 Months Ended | |
|---|---|---|
|
May 31, 2022
USD ($)
item
|
May 31, 2021
USD ($)
item
|
|
| Concentration Risk [Line Items] | ||
| Accounts payable | $ 67,974 | $ 65,897 |
| Number of vendors | item | 2 | 2 |
| Compensation and related expense | $ 1,504 | $ 4,005 |
| Legal fees and settlement | 2,006 | 11,008 |
| Clinical expenses | 3,727 | 1,462 |
| Other liabilities | 1,624 | 2,598 |
| Total accrued liabilities | $ 8,861 | 19,073 |
| Accrued legal settlement | $ 10,600 | |
| Accounts Payable | Credit Availability Concentration Risk [Member] | Vendor One [Member] | ||
| Concentration Risk [Line Items] | ||
| Concentration Risk, Percentage | 57.00% | 72.00% |
| Accounts Payable | Credit Availability Concentration Risk [Member] | Vendor Two [Member] | ||
| Concentration Risk [Line Items] | ||
| Concentration Risk, Percentage | 17.00% | 14.00% |
| X | ||||||||||
- Definition Amount of accrued clinical expenses. No definition available.
|
| X | ||||||||||
- Definition Total of carrying values as of the balance sheet date of obligations incurred through that date, classified as current, and payable for compensation-related and other accrued liabilities besides those related to financing activities. No definition available.
|
| X | ||||||||||
- Definition The number of counterparties in the relationship represented, at balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|